Mounjaro manufacturer rejects PBS recommendation Eli Lilly will not list tirzepatide on the PBS for type 2 diabetes despite PBAC recommendation, claiming the advice came with ‘unrealistic’ price conditions.
Declining vaccination rates spark major national campaigns They aim to bolster COVID-19, flu, and RSV jabs, but an expert says the ‘generic’ campaigns fail to leverage trust in GPs.
‘Too early’ to say Alzheimer’s drugs don’t work, say GP experts A Cochrane review says the efficacy of amyloid-targeting drugs is ‘trivial’. Two GPs say it’s a premature call.
Dr Clara Tuck Meng Soo calls time on practice While the national leader in transgender health has retired from general practice, her advocacy work will continue.
‘Good progress’: RSV vaccine made free for older Australians From 15 May this year, eligibility for a free RSV vaccine will expand to those aged over 75 for the first time.
‘Good asthma management’ crucial for GPs A Queensland study on children’s asthma hospitalisations highlights the importance of management plans in all climate zones, says an expert.
ATAGI warns of pertussis risk for older adults The advisory group has described vaccination rates among at-risk groups as ‘suboptimal’, saying the disease is ‘not only a disease of childhood’.
Have your say on the Health of the Nation The RACGP’s annual survey has become ‘critical’ to helping GPs, and the college, shape the future of general practice.
Nasal spray flu vaccine expansion continues Amid a widening rollout of the needle-free vaccine, GPs already administering the treatment say it’s been a ‘really exciting’ and practical change to everyday practice.
Medical Costs overhaul creates ‘substantial uncertainty’ for GPs The RACGP says a plan to publish individual GP fees could create misleading comparisons, influence billing behaviour, and impact practice sustainability.